Epristeride
CAS: 119169-78-7
Ref. TM-T15239
1mg | 98.00 € | ||
2mg | 144.00 € | ||
5mg | 233.00 € | ||
10mg | 374.00 € | ||
25mg | 750.00 € | ||
1ml*10 (DMSO) | 257.00 € |
Product Information
- SKF105657, ONO-9302
- (17b)-17-[[(1,1-Dimethylethyl)amino]carbonyl]androsta-3,5-diene-3-carboxylic Acid
- (17beta)-17-(tert-Butylcarbamoyl)androsta-3,5-diene-3-carboxylic acid
- 119169-78-7
- 17-(Tert-Butylcarbamoyl)Androsta-3,5-Diene-3-Carboxylic Acid
- 17β-(tert-Butylcarbamoyl)androsta-3,5-diene-3-carboxylic acid
- Androsta-3,5-Diene-3-Carboxylic Acid, 17-[[(1,1-Dimethylethyl)Amino]Carbonyl]-, (17Beta)-
- Androsta-3,5-diene-3-carboxylic acid, 17-[[(1,1-dimethylethyl)amino]carbonyl]-, (17β)-
- N-tert-Butylandrosta-3,5-diene-17β-carboxamide-3-carboxylic acid
- Ono 9302
- See more synonyms
- Skf 105657
Epristeride (ONO-9302) is an orally active, selective and non-competitive steroidal 5-α-reductase isoform 2 inhibitor that inhibits SR isoform 2.Episteride reduces prostate size and improves symptoms in men with BPH.Episteride induces atrophy and apoptosis of the ventral prostate in rats.
Chemical properties
Technical inquiry about: TM-T15239 Epristeride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.